Industry NewsFDA approves GSK’s BLENREP for the treatment of patients with relapsed or refractory multiple myeloma
Editorial ArticlePreventing DNA Contamination: Tackling the Phantom of Heilbronn Legacy with Eppendorf
Editorial ArticleHarnessing the Power of 3D Pharmacology for Improved In Vitro to In Vivo Predictions
Expert InsightsEnhancing LC-MS analysis of oligos, peptides, and glycans using hybrid surface technology: Your questions answered